PerkinElmer and JMC Collaborate to Develop Molecular Diagnostics Screening Platforms
Complete the form below to unlock access to ALL audio articles.
PerkinElmer, Inc. has announced a research collaboration agreement with Jacobi Medical Center, which is currently developing a centralized molecular genetics diagnostic laboratory that will ultimately serve the Health and Hospitals Corporation (HHC) of New York City.
The collaboration will focus on the development of a genetic screening platform for neonatal, pre-natal and maternal/adult healthcare.
Through the agreement, PerkinElmer will provide Jacobi Medical Center with innovative bead-based multiplex technologies intended to identify and validate biomarkers for genetic diseases.
"Collaborating with Jacobi Medical Center represents an exciting expansion in our program to partner with research institutions and research hospitals to accelerate biomarker discovery and genetic screening," said Ann-Christine Sundell, vice president, genetic screening for PerkinElmer Life and Analytical Sciences.
"Jacobi Medical Center has unique expertise in the area of genetically inherited diseases and access to a large patient population. Together, we hope to improve the efficacy of screening for disorders in adults and children at risk."
"Jacobi Medical Center's primary mission is to provide the highest quality and most cost-effective health care possible for our patients," said Dr. Susan Gross, Jacobi Medical Center.
"By combining our clinical research and patient care with PerkinElmer's proven technology and capabilities, Jacobi Medical Center will help advance clinical genetic screening and biomarker discovery for our neonatal, pre-natal and maternal healthcare patients in New York."
